Litigation Details for NOVARTIS PHARMACEUTICALS CORPORATION v. PAR STERILE PRODUCTS, LLC (D.N.J. 2014)
✉ Email this page to a colleague
NOVARTIS PHARMACEUTICALS CORPORATION v. PAR STERILE PRODUCTS, LLC (D.N.J. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-12-02 |
| Court | District Court, D. New Jersey | Date Terminated | 2015-05-13 |
| Cause | 35:271 Patent Infringement | Assigned To | Susan Davis Wigenton |
| Jury Demand | Defendant | Referred To | Steven C. Mannion |
| Patents | 7,932,241; 8,052,987; 8,324,189 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in NOVARTIS PHARMACEUTICALS CORPORATION v. PAR STERILE PRODUCTS, LLC
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for NOVARTIS PHARMACEUTICALS CORPORATION v. PAR STERILE PRODUCTS, LLC (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-12-02 | 1 | expiration of U.S. Patent Nos. 7,932,241 (“the ’241 patent”), 8,052,987 (“the ’987 patent”), and 8,324,189… 2. This is an action for patent infringement under the patent laws of the United States, Title…life of three years. B. The Patents-In-Suit 15. The ’241 patent, entitled “Pharmaceutical products…. A copy of the ’241 patent is attached as Exhibit A. 16. The ’987 patent, entitled “Method of…. A copy of the ’987 patent is attached as Exhibit B. 17. The ’189 patent, entitled “Use of zolendronate | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
